Pharma Reviews: High Demand for Laboratory and Analytical Equipments Witnessed at analytica Anacon India and ...

Some of the leading companies participated in the show were Ministry of Defence, DUPONT, Aurobindo Pharma, Bharat Biotech, Indian Institute of ...
Read more: High Demand for Laboratory and Analytical Equipments Witnessed at analytica Anacon India and ...

Pharma Reviews: Indian Pharma Majors Lose Share To Smaller Drugmakers In US Markets

Smaller Indian drugmakers are eating into the share of their local big brothers in the U.S. market. And if brokerage firm Jefferies is to be believed, their ...
Read more: Indian Pharma Majors Lose Share To Smaller Drugmakers In US Markets

Pharma Reviews: Recommendation From Pharmaceuticals Sector

The pharmaceutical industry is one of the biggest and fastest growing industries in India. Gufic Biosciences Limited is one of the fast growing company ...
Read more: Recommendation From Pharmaceuticals Sector

US FDA News: FDA improves access to reports of adverse drug reactions

The U.S. Food and Drug Administration today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA’s Adverse Event Reporting System (FAERS). The tool is designed to make it easier for consumers, providers, and researchers to access this information.
Read more: FDA improves access to reports of adverse drug reactions

US FDA News: FDA approves new treatment for certain advanced or metastatic breast cancers

The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy).
Read more: FDA approves new treatment for certain advanced or metastatic breast cancers

US FDA News: Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use

Type III endoleak may require treatment with additional interventions such as re-lining, insertion of additional endograft components, or open surgical repair. Interventions to address endoleaks carry added risks for impacted patients.
Read more: Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use

Pharma Reviews: 12 Indian manufactures win Pacmachine Awards 2017

Twelve Indian machine manufacturers were honoured during the ... Sun Pharmaceutical Industries won the award for its world first drop size testing ...
Read more: 12 Indian manufactures win Pacmachine Awards 2017

Pharma Reviews: Leading Trade Fair for Powder, Bulk Solids and Process Technologies now in India

Mumbai : Powder and Bulk Solids India is now been rebranded as ... with increased demand from the pharmaceutical, chemical and food sectors.
Read more: Leading Trade Fair for Powder, Bulk Solids and Process Technologies now in India

Pharma Reviews: How to survive a perfect storm in pharma sector: Ravi Dharamshi, ValueQuest

But it reflects very poorly on Indian pharma companies with their chalta hai attitude. Two years ago we thought that they had the finest R&D labs and ...
Read more: How to survive a perfect storm in pharma sector: Ravi Dharamshi, ValueQuest

Pharma Reviews: Weakening INR to put some fresh breath in IT and Pharma

The Indian rupee has depreciated ~2.8% in last one month against US ... Rupee downtrend will provide some fresh breath to Pharma and IT sector, ...
Read more: Weakening INR to put some fresh breath in IT and Pharma

Pharma Reviews: Pharmacists and experts urge govt to frame an Act for pharmaceutical waste management

Need of safe disposal of pharmaceutical waste and a self-contained ... for the release of pharma waste into rivers or the environment in India, more ...
Read more: Pharmacists and experts urge govt to frame an Act for pharmaceutical waste management

Pharma Reviews: CIPI urges govt to create enabling environment for SSIs for playing key role in making drugs ...

... affordable prices, one of the main objectives of draft pharmaceutical policy, the Confederation of Indian Pharmaceutical Industry (CIPI) has appealed ...
Read more: CIPI urges govt to create enabling environment for SSIs for playing key role in making drugs ...

Pharma Reviews: Spanish pharma MNC to invest 500 cr in Telangana State

Hyderabad: Chemo Group, a multinational pharma company from Spain, on Wednesday announced plans for investing about Rs 500 crore in phases ...
Read more: Spanish pharma MNC to invest 500 cr in Telangana State

US FDA News: FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration

The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip (often referred to as a “fingerstick”).
Read more: FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration

Pharma Reviews: need2know: 10 macro cues for your day on D-Street

Indian pharma exporters' road to recovery might still take time as weak ... While the LATAM market growth declined by 7% year on year, the African ...
Read more: need2know: 10 macro cues for your day on D-Street

Pharma Reviews: Pharma companies lag in digital journey against global counterparts

MUMBAI: Indian pharmaceutical companies lag behind in their digital journey as compared to their global counterparts, according to a industry report.
Read more: Pharma companies lag in digital journey against global counterparts

Pharma Reviews: Indian pharma lags behind digital adoption, says EY study

Indian pharmaceutical companies lag their global peers in digital adoption, and less than 10 per cent of them have a comprehensive strategy in place, ...
Read more: Indian pharma lags behind digital adoption, says EY study

Pharma Reviews: Indian pharma cos lag in digital race against global counterparts: EY

Indian pharmaceutical companies lag behind in their digital journey as compared to their global counterparts, according to a industry report.
Read more: Indian pharma cos lag in digital race against global counterparts: EY

Pharma Reviews: Pharma cos lag in digital journey against global counterparts

Mumbai, Sep 27 (PTI) Indian pharmaceutical companies lag behind in their digital journey as compared to their global counterparts, according to a ...
Read more: Pharma cos lag in digital journey against global counterparts

Pharma Reviews: Glenmark Pharma: Recent approvals to help scale up FY18 growth

On the India revenue front, the company has been outperforming the overall pharma market sales with a growth of 10.5 per cent for the trailing twelve ...
Read more: Glenmark Pharma: Recent approvals to help scale up FY18 growth

Pharma Reviews: Abbott's decision to pull out Xience Alpine stent won't impact Indian patients, claim health activists

Earlier on Tuesday, drug price regulator National Pharmaceutical Pricing Authorit (NPPA) gave a formal approval to drug maker Abbott Healthcare to ...
Read more: Abbott's decision to pull out Xience Alpine stent won't impact Indian patients, claim health activists

Pharma Reviews: Leading Trade Fair for Powder, Bulk Solids and Process Technologies now in India

Powder & Bulk Solids India is now been rebranded as POWTECH India in ... increased demand from the pharmaceutical, chemical and food sectors.
Read more: Leading Trade Fair for Powder, Bulk Solids and Process Technologies now in India

Pharma Reviews: Sensex falls 183 points; Sun Pharma, Adani Ports top losers

Indian equities continued to decline for the seventh day on Wednesday. ... Major losers in the 30-share index were Sun Pharmaceutical Industries ...
Read more: Sensex falls 183 points; Sun Pharma, Adani Ports top losers

Pharma Reviews: As markets correct, bet on these 3 themes: Saurabh Mukherjea, Ambit Capital

The fear side of the stock market, you are taking FD action over the last two years and we are extrapolating that to Indian pharma saying that Indian ...
Read more: As markets correct, bet on these 3 themes: Saurabh Mukherjea, Ambit Capital

Pharma Reviews: Pharmaceutical exports poised to grow 3-5 per cent this year: Pharmexcil

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) during its 13th annual general body meeting held in Hyderabad expressed ...
Read more: Pharmaceutical exports poised to grow 3-5 per cent this year: Pharmexcil

Pharma Reviews: IDMA & NSF propels Pharmaceutical Quality Management Systems to stall non-compliance at ...

Indian Drug Manufacturers Association (IDMA) and NSF Health Sciences, UK will spur Pharmaceutical Quality Management Systems across Indian ...
Read more: IDMA & NSF propels Pharmaceutical Quality Management Systems to stall non-compliance at ...

Pharma Reviews: Avenue Supermarts Jumps Most Since Listing After Goldman's 'Buy' Rating

Shares of Avenue Supermarts Ltd. rose as much as 18.3 percent, the most since its March 21 listing, to a record after Goldman Sachs initiated ...
Read more: Avenue Supermarts Jumps Most Since Listing After Goldman's 'Buy' Rating

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to encourage compounding of better quality drugs under DQSA and help health care professionals access compounded medications needed for patient care from outsourcing facilities

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to encourage compounding of better quality drugs under DQSA and help health care professionals access compounded medications needed for patient care from outsourcing facilities
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to encourage compounding of better quality drugs under DQSA and help health care professionals access compounded medications needed for patient care from outsourcing facilities

US FDA News: Federal judge orders Flawless Beauty to stop distributing unapproved drugs, recall certain products

A federal judge ordered a New Jersey company that sold injectable skin whitening and other beauty products to stop selling and recall some of its products because they are unapproved new drugs that may be unsafe, putting consumers at risk.
Read more: Federal judge orders Flawless Beauty to stop distributing unapproved drugs, recall certain products

Pharma Reviews: Weakening Semi-Regulated Markets Weighing On Indian Pharma Exporters

Weakening Semi-Regulated Markets Weighing On Indian Pharma Exporters ... In the financial year 2016-17 (FY17), India's exports of pharmaceutical ...
Read more: Weakening Semi-Regulated Markets Weighing On Indian Pharma Exporters

Pharma Reviews: India's NMDC to Seek Major Investor in Its First Steel Plant

(Bloomberg) -- India's top iron ore miner NMDC Ltd. is looking to sell a ... the official said Monday, declining to be named in line with company policy.
Read more: India's NMDC to Seek Major Investor in Its First Steel Plant

Pharma Reviews: Jaguar Land Rover Needs More Than a Luxury Brand Halo

Since the acquisition, the Indian company has failed to bring the kind of cost ... Shelly Banjo is a Bloomberg Gadfly columnist covering industrial ...
Read more: Jaguar Land Rover Needs More Than a Luxury Brand Halo

Pharma Reviews: Delhi High Court Seeks Bakshi's Reply On McDonald's Plea To Enforce Arbitral Award

The Delhi High Court sought response of Vikram Bakshi, estranged partner of McDonald's India on the company's plea seeking enforcement of an ...
Read more: Delhi High Court Seeks Bakshi's Reply On McDonald's Plea To Enforce Arbitral Award

Pharma Reviews: Weak global eco conditions may hit pharma exporters: Ind-Ra

In FY17, India's exports of pharmaceutical formulations or finished products to the semi-regulated markets grew at the weakest pace of 0.7 percent in ...
Read more: Weak global eco conditions may hit pharma exporters: Ind-Ra

Pharma Reviews: CVC Is Said to Mull Options for $4 Billion Drugmaker Alvogen

(Bloomberg) -- Alvogen's private equity owners including CVC Capital Partners are exploring options for the generic pharmaceutical company, which ...
Read more: CVC Is Said to Mull Options for $4 Billion Drugmaker Alvogen

US FDA News: FDA selects participants for new digital health software precertification pilot program

Today, the U.S. Food and Drug Administration announced the names of the companies selected to participate in a first-of-its kind pilot program that will help revolutionize digital health regulation in the U.S.
Read more: FDA selects participants for new digital health software precertification pilot program

Pharma Reviews: Nifty, Sensex May Rise If Tuesday's Low Holds – Tuesday closing report

The major indices of the Indian stock markets were range-bound on ... The Indian pharmaceutical sector, which has witnessed tepid growth on the ...
Read more: Nifty, Sensex May Rise If Tuesday's Low Holds – Tuesday closing report

Pharma Reviews: Weak global eco conditions may hit pharma exporters: Ind-Ra

In FY17, India's exports of pharmaceutical formulations or finished products to the semi-regulated markets grew at the weakest pace of 0.7 per cent in ...
Read more: Weak global eco conditions may hit pharma exporters: Ind-Ra

Pharma Reviews: Currency fluctuation in semi regulated markets to hit Indian pharma: Fitch

India's pharma exports to the semi regulated markets of LATAM and Africa had proved to be a robust market up until 2014, however in FY17 India's ...
Read more: Currency fluctuation in semi regulated markets to hit Indian pharma: Fitch

Pharma Reviews: Weak global eco conditions may hit pharma exporters: Ind-Ra

Weak global eco conditions may hit pharma exporters: Ind-Ra ... countries are likely to affect medium term growth of Indian pharmaceutical exporters, ...
Read more: Weak global eco conditions may hit pharma exporters: Ind-Ra

Pharma Reviews: IT action on USV India puts spotlight on pharma marketing code, tax rules

The Times of India reported on Tuesday that the I-T department had unearthed a nexus between the pharmaceutical company and doctors and had ...
Read more: IT action on USV India puts spotlight on pharma marketing code, tax rules

Product Recall Alerts: Preparing for the Inevitable: Key Steps for Weathering a Pharmaceutical Recall

There were 11.6 million Class I pharmaceutical units recalled in Q2, making ... There are also complex regulatory requirements for coordinating the notification and response, product retrieval, storage, and ultimate product disposition ...
Read more: Preparing for the Inevitable: Key Steps for Weathering a Pharmaceutical Recall

Pharma Reviews: Cheap drugs pay for Aurobindo Pharma as USFDA approvals surge

Mumbai: While India's largest pharmaceutical companies have seen drug approvals in the US slow overall, their research and development (R&D) ...
Read more: Cheap drugs pay for Aurobindo Pharma as USFDA approvals surge

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA actions to bring relief to citizens of Puerto Rico; to help the island recover its considerable and economically vital medical product manufacturing base; and to prevent critical shortages of life-saving drugs made in Puerto Rico

As an agency dedicated to promoting public health, and as fellow Americans, the staff at the U.S. Food and Drug Administration is doing all it can to support the immediate needs of Puerto Ricans following the destruction of Hurricane Maria. First and foremost, these efforts are focused around our mission driven responsibilities to ensure the safety of the medical products, blood and the food supply needed by residents of the island. Our efforts also encompass challenges that are unique to Puerto Rico. The island is home to a substantial base of manufacturing for critical medical products that supply the entire world. This industrial base is an important source of jobs and economic vitality for the island. It is a key to Puerto Rico’s economic recovery. The manufacturing facilities are also a pivotal source of critical medical products for the entire United States. Helping to bring these resources back in operation is an important goal of ours and of Puerto Rico’s.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA actions to bring relief to citizens of Puerto Rico; to help the island recover its considerable and economically vital medical product manufacturing base; and to prevent critical shortages of life-saving drugs made in Puerto Rico

Pharma Reviews: Normalcy in pharma sector expected by 2021: Lupin CFO

New Delhi, Sep 25 (IANS) The Indian pharmaceutical sector, which has witnessed tepid growth on the domestic and international fronts, is likely to see ...
Read more: Normalcy in pharma sector expected by 2021: Lupin CFO

Pharma Reviews: World Pharmacist Day celebrated

Hyderabad: Indian Pharmaceutical Association – Telangana State Branch in collaboration with Sultan-ul-Uloom College of Pharmacy organised a ...
Read more: World Pharmacist Day celebrated

US FDA News: Bridge Occlusion Balloon Catheter Model 590-001 by Spectranetics: Class I Recall - Clinical Issue

If device with blocked guidewire lumen were used, device would not be positioned correctly and hemorrhage would not be controlled, delaying life-saving treatment, which may result in serious adverse health consequences, including death.
Read more: Bridge Occlusion Balloon Catheter Model 590-001 by Spectranetics: Class I Recall - Clinical Issue

US FDA News: TAH-t Companion 2 Driver System (C2) and Freedom Driver System by SynCardia Systems: Letter to Health Care Providers - Mortality and Neurological Adverse Event Results

UPDATED 09/25/2017. Most recent interim results from the ongoing SynCardia TAH-t post-approval study looking at mortality and neurological adverse events.
Read more: TAH-t Companion 2 Driver System (C2) and Freedom Driver System by SynCardia Systems: Letter to Health Care Providers - Mortality and Neurological Adverse Event Results

Pharma Reviews: Pharma majors knock at Niti Aayog's doors with concerns over new drug policy

MUMBAI: Indian drug companies have approached the government's think tank Niti Aayog, seeking some changes in the recently floated draft drug ...
Read more: Pharma majors knock at Niti Aayog's doors with concerns over new drug policy

Pharma Reviews: World Pharmacists Day 2017: A Brief History of Pharmacy And Pharmacists In India

The Pharmacy industry grew and developed rapidly in the country post that. As of today, it is the ranked 4th in terms of volume and 14th as far as the ...
Read more: World Pharmacists Day 2017: A Brief History of Pharmacy And Pharmacists In India

US FDA News: FDA conducts major global operation to protect consumers from potentially dangerous prescription drugs sold online

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved versions of prescription medicines, including opioids, antibiotics and injectable epinephrine products to American consumers.
Read more: FDA conducts major global operation to protect consumers from potentially dangerous prescription drugs sold online

Pharma Reviews: Bihar drug controller bans ofloxacin, pharma MSMEs seek clarification

... without issuing the proper show-cause and inviting replies, pharma MSME association Confederation of Indian Pharmaceutical Industry (CIPI) said.
Read more: Bihar drug controller bans ofloxacin, pharma MSMEs seek clarification

Pharma Reviews: Normalcy in pharma sector expected by 2021: Lupin CFO

The Indian pharmaceutical sector, which has witnessed tepid growth on the domestic and international fronts, is likely to see return of normalcy only by ...
Read more: Normalcy in pharma sector expected by 2021: Lupin CFO

Pharma Reviews: India's unpredictable drug pricing regime will have severe impact on doing business in India ...

The draft Pharmaceutical Policy, released recently by the Department of Pharmaceuticals (DoP), covers several aspects affecting the industry.
Read more: India's unpredictable drug pricing regime will have severe impact on doing business in India ...

Pharma Reviews: CIPI seeks clarification from Bihar DC for ban of formulations of levofloxacin and ofloxacin for ...

The Confederation of Indian Pharmaceutical Industry (CIPI), the apex body of small scale drug manufacturers in the country, has sought clarification ...
Read more: CIPI seeks clarification from Bihar DC for ban of formulations of levofloxacin and ofloxacin for ...

Pharma Reviews: CIPI expresses reservations over scrapping of loan license and mandatory BA/BE testing in draft ...

The Confederation of Indian Pharmaceutical Industry (CIPI), the apex body of small scale manufacturers of drugs and pharmaceuticals in India, has ...
Read more: CIPI expresses reservations over scrapping of loan license and mandatory BA/BE testing in draft ...

Pharma Reviews: Focus: Destination Malta

Indian pharmaceutical company Aurobindo Pharma, which established its first European GMP certified facility in Malta in 2008, launched its products ...
Read more: Focus: Destination Malta

Pharma Reviews: Pharma industry experts unite

Pharmaceutical Export Promotion Council of India (Pharmexcil) as part of its 13th-anniversary celebrations recently conducted a seminar on 'Risk ...
Read more: Pharma industry experts unite

Pharma Reviews: Deepak Fertilisers to set up brownfield IPA plant at Tajola

The Indian pharma industry has been growing at a compounded double-digit growth rate over the last five years and has significant growth potential.
Read more: Deepak Fertilisers to set up brownfield IPA plant at Tajola

Pharma Reviews: India working to cut imports of active pharmaceutical ingredients

Pharmexcil has identified about 100 molecules and laboratories that have capabilities to make them; results to take about 18 months.
Read more: India working to cut imports of active pharmaceutical ingredients

Pharma Reviews: Small-cap wrap: ITI, Orchid Pharma, SMS Pharma gains the most

Small-cap pharma stocks including Orchid Pharma, SMS Pharma and ... Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be ... stocks on NSE, reflecting strong negative sentiments floating in the market.
Read more: Small-cap wrap: ITI, Orchid Pharma, SMS Pharma gains the most

Pharma Reviews: May Hit by Credit Rating Blow as She Reboots UK Brexit Plan

While both other major rating companies downgraded Britain shortly after the .... Has anything fundamentally changed for Indian pharma companies?
Read more: May Hit by Credit Rating Blow as She Reboots UK Brexit Plan

Pharma Reviews: India's drug prices regulator calls for better oversight of private hospitals

By Zeba Siddiqui. MUMBAI - India's drug pricing authority called for better regulation of the country's massive private healthcare industry on Friday to ...
Read more: India's drug prices regulator calls for better oversight of private hospitals

Pharma Reviews: Cut In Interconnect Usage Charges To Impact EBITDA Levels Of Incumbents By 4-5%

India Ratings estimates the impact of the cut on the standalone leverage .... Has anything fundamentally changed for Indian pharma companies?
Read more: Cut In Interconnect Usage Charges To Impact EBITDA Levels Of Incumbents By 4-5%

Pharma Reviews: Natco Pharma: Health begins at home

Natco Pharma: Health begins at home ... Many Indian pharmaceutical companies have been on the back foot over the last couple of years — caught in ...
Read more: Natco Pharma: Health begins at home

Pharma Reviews: Pharma exports pick up in August; but still down compared to last year

The Pharmexcil is working along with Government of India, industry and research institutions for import substitution as Indian pharma industry now has ...
Read more: Pharma exports pick up in August; but still down compared to last year

Pharma Reviews: S. Africa Mulls Review of KPMG Contracts Amid Gupta Fallout

In terms of positives, liquidity has had the upper hand not just for India, but ... Has anything fundamentally changed for Indian pharma companies?
Read more: S. Africa Mulls Review of KPMG Contracts Amid Gupta Fallout

Pharma Reviews: Zuckerberg Plans to Sell as Much as 18% of His Facebook Shares

Has anything fundamentally changed for Indian pharma companies? Is it time to re-look at some of the pharma names or you still remain cautious?
Read more: Zuckerberg Plans to Sell as Much as 18% of His Facebook Shares

Pharma Reviews: 7th season on 'Emerging Trends in Injectable Market' organized by Becton Dickinson

The global injectable drug delivery devices market is also expected to ... Pharma industry is one of the major contributors to Indian economy, and ...
Read more: 7th season on 'Emerging Trends in Injectable Market' organized by Becton Dickinson

Pharma Reviews: MIAL to have half a million tonnes capacity pharma terminal

As the dynamic growth of Indian pharma industry positions it as the third largest pharmaceuticals market in the world in terms of value and eleventh ...
Read more: MIAL to have half a million tonnes capacity pharma terminal

Pharma Reviews: Facebook Scraps New Share Class in Rare Win for Investors

(Bloomberg) -- Facebook Inc. scrapped plans to create a new class of shares, a rare victory for outside investors in a battle for control of the world's ...
Read more: Facebook Scraps New Share Class in Rare Win for Investors

Pharma Reviews: GST-Related Disruptions May Last Three Months, Says Andrew Holland

Lot of companies facing working capital problems with GST, and growth is not ... Has anything fundamentally changed for Indian pharma companies?
Read more: GST-Related Disruptions May Last Three Months, Says Andrew Holland

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s immediate steps to respond to Hurricane Maria and ongoing recovery efforts related to Hurricane’s Harvey and Irma

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s immediate steps to respond to Hurricane Maria and ongoing recovery efforts related to Hurricane’s Harvey and Irma
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s immediate steps to respond to Hurricane Maria and ongoing recovery efforts related to Hurricane’s Harvey and Irma

US FDA News: Criminal and civil actions filed against Aegerion Pharmaceuticals Inc.

Aegerion Pharmaceuticals Inc. agreed to plead guilty in the United States District Court for the District of Massachusetts to two misdemeanor counts of violating the Federal Food, Drug, and Cosmetic Act (FD&C Act) involving the introduction of misbranded Juxtapid (lomitapide) into interstate commerce.
Read more: Criminal and civil actions filed against Aegerion Pharmaceuticals Inc.

Pharma Reviews: BJP targets Rajya Sabha member Prasanna Acharya on pharma, chit companies

BHUBANESWAR: Stepping up attack on the ruling BJD, the BJP on Thursday demanded that Rajya Sabha member and former health minister ...
Read more: BJP targets Rajya Sabha member Prasanna Acharya on pharma, chit companies

Pharma Reviews: Indian exports may not gain much from rise in global trade

For pharmaceutical products, the US is a major market for Indian generics, almost half of which, by volume, reach US shores. "In the United States, ...
Read more: Indian exports may not gain much from rise in global trade

Pharma Reviews: India's drug prices regulator calls for better oversight of private hospitals

India's drug pricing authority called for better regulation of the country's massive private healthcare industry on Friday to ensure government efforts to ...
Read more: India's drug prices regulator calls for better oversight of private hospitals

Pharma Reviews: India's drug prices regulator calls for better oversight of private hospitals

MUMBAI (Reuters) - India's drug pricing authority called for better regulation of the country's massive private healthcare industry on Friday to ensure ...
Read more: India's drug prices regulator calls for better oversight of private hospitals

Pharma Reviews: Tenth edition of analytica Anacon India and India Lab expo starts in Hyderabad

The entire area of analytical technology is very critical for pharma industry. The future of pharma industry whether it is on generic side of innovative ...
Read more: Tenth edition of analytica Anacon India and India Lab expo starts in Hyderabad

Pharma Reviews: 'Pre-filled syringes emerging as one of the fastest-growing choices'

Pharma industry is one of the major contributors to Indian economy, and therefore to safeguard the interest of patients as well as investors, it is ...
Read more: 'Pre-filled syringes emerging as one of the fastest-growing choices'

Pharma Reviews: 10th Edition of analytica Anacon India and India Lab Expo Opens on a High Note

The entire area of analytical technology is very critical for Pharma industry. The future of Pharma whether it is on generic side of innovative side ...
Read more: 10th Edition of analytica Anacon India and India Lab Expo Opens on a High Note

Pharma Reviews: Buy Lupin; target of Rs 1125: Motilal Oswal

Key takeaways: Mr Gupta has categorized the evolution of the Indian pharmaceutical industry into Wave 1, Wave 2 and Wave 3. According to him, the ...
Read more: Buy Lupin; target of Rs 1125: Motilal Oswal

Pharma Reviews: Health ministry sensitizes pharma cos to set up PV cells for monitoring ADRs

In order to equip and sensitise Indian pharma companies to set up pharmacovigilance (PV) cells for generating adverse drug reaction (ADR) data, ...
Read more: Health ministry sensitizes pharma cos to set up PV cells for monitoring ADRs

Pharma Reviews: BJP targets Acharya on pharma, chit companies

The chit fund company, which had no experience in the manufacturing of pharmaceutical products, had signed a `80-crore drug manufacturing deal ...
Read more: BJP targets Acharya on pharma, chit companies

Pharma Reviews: Pharma stocks soar after USFDA, other approvals

The Hyderabad-based drug firm informed exchanges that it has received an ... Axis Capital, in a research report, said it expects recovery for most Indian Pharma companies by September quarter of financial year 2018 (Q2FY18).
Read more: Pharma stocks soar after USFDA, other approvals

Pharma Reviews: For Lupin in US, next 2 years will be a challenge, says Motilal Oswal

Gupta believes that the domestic market can continue recording a 12% ... Gupta has categorised the evolution of the Indian pharmaceutical industry ...
Read more: For Lupin in US, next 2 years will be a challenge, says Motilal Oswal

Pharma Reviews: Clinical trials: Govt may tighten rules for compensation

New Delhi: Drug companies conducting clinical trials in India must pay up 60% of the compensation amount within 15 days if a patient dies or suffers a ...
Read more: Clinical trials: Govt may tighten rules for compensation

US FDA News: Vegetable Vigra by Natures Supplement: Recall - Undeclared Drug Ingredient

Men with diabetes, high blood pressure, high cholesterol, or heart disease, may be on medications that, taken with this product, could lower blood pressure to dangerous levels that could be life-threatening.
Read more: Vegetable Vigra by Natures Supplement: Recall - Undeclared Drug Ingredient

Pharma Reviews: 20 years of training job aspirants

In fact, Europe could be the next big destination for skilled Indian workforce,” ... Pharma industry, Internet of Things, and supply chain management among others. ... for skilled candidates, provided they get right industrial exposure.
Read more: 20 years of training job aspirants

US FDA News: Ocaliva (obeticholic acid): Drug Safety Communication - Increased Risk of Serious Liver Injury

Reports of Ocaliva being incorrectly dosed in some patients with moderate to severe decreases in liver function. Some patients received a higher frequency of dosing than is recommended in the drug label.
Read more: Ocaliva (obeticholic acid): Drug Safety Communication - Increased Risk of Serious Liver Injury

Pharma Reviews: Mankind Pharma gearing up to enter US, may start product filings in FY18

Mumbai: India's fourth largest drug maker Mankind Pharma Ltd is working to make inroads in the lucrative US market and plans to file its first set of ...
Read more: Mankind Pharma gearing up to enter US, may start product filings in FY18

Pharma Reviews: Market Live: Sensex under pressure as rupee hits 2-month low; Pharma up 3%

Market Live: Sensex under pressure as rupee hits 2-month low; Pharma up 3% ... The move would help in cutting down the diesel expenses on Indian ...
Read more: Market Live: Sensex under pressure as rupee hits 2-month low; Pharma up 3%

Pharma Reviews: Centre to make North East, a hub of Biotechnology

The Department of Biotechnology (DBT) government of India has launched ... on sustainable basis for a boom in the phyto-pharmaceutical industry.
Read more: Centre to make North East, a hub of Biotechnology

US FDA News: Rhino 7, Papa Zen, Fifty Shades, and Grande X Dietary Supplements by Gadget Island: Recall - Undeclared Drug Ingredients

Use of products with undeclared active ingredients sildenafil, tadalafil and desmethyl carbodenafil may interact with nitrates and may cause a significant drop in blood pressure that may be life threatening.
Read more: Rhino 7, Papa Zen, Fifty Shades, and Grande X Dietary Supplements by Gadget Island: Recall - Undeclared Drug Ingredients

US FDA News: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

Health care professionals should develop a treatment plan when buprenorphine or methadone is used in combination with benzodiazepines or other CNS depressants.
Read more: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s continued efforts to promote the safe adoption of medication-assisted treatment for opioid addiction

Medication-assisted treatment (MAT) – the use of medication combined with counseling and behavioral therapies – is one of the major pillars of the federal response to the opioid epidemic in this country. This type of treatment is an important tool that has the potential to help millions of Americans with an opioid use disorder regain control over their lives. In fact, patients receiving MAT cut their risk of death from all causes in half, according to the Substance Abuse and Mental Health Services Administration. Addressing the epidemic of opioid addiction is my highest public health priority. One element of that effort is promoting more widespread, safe adoption of MAT as a way to help more people overcome addiction.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s continued efforts to promote the safe adoption of medication-assisted treatment for opioid addiction

US FDA News: FDA clears first duodenoscope with disposable distal cap

The U.S. Food and Drug Administration today cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems.
Read more: FDA clears first duodenoscope with disposable distal cap

Pharma Reviews: Russia and India embark on transfer of technologies of drugs production for treatment of HIV infection

At the same time, the corporation is ready for a technological partnership in the pharmaceutical industry. "We are developing our own drug production, ...
Read more: Russia and India embark on transfer of technologies of drugs production for treatment of HIV infection

Pharma Reviews: Exclusive: Home healthcare aggregator HealWell24 raises angel funding

The funds were raised from a chief information officer of a major Indian pharmaceuticals multinational company, a financial and media executive, and ...
Read more: Exclusive: Home healthcare aggregator HealWell24 raises angel funding

Pharma Reviews: Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin

ET Now: Indian pharma has hit a speed breaker and a solid one at that, something that has really stalled things for a while with the USFDA relations ...
Read more: Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin

Pharma Reviews: US FDA Completes Re-Inspection Of Unit-2 Of Divi's Laboratories' Visakhapatnam Facility

The outcome of the re-inspection is a positive development for the Indian pharmaceutical industry reeling under stress of maintaining high compliance ...
Read more: US FDA Completes Re-Inspection Of Unit-2 Of Divi's Laboratories' Visakhapatnam Facility

Pharma Reviews: NIPER, Mohali conducts two-week training program on 'Pharmaceutical Quality by Design: A Risk ...

The National Institute of Pharmaceutical Education & Research (NIPER), ... Government of India under Indian Technical and Economic Cooperation ...
Read more: NIPER, Mohali conducts two-week training program on 'Pharmaceutical Quality by Design: A Risk ...

Pharma Reviews: Maha FDA calls for joint efforts with pharma industry to fight against counterfeit drugs

The drug survey was conducted by Noida based National Institute of Biologicals (NIB) in collaboration with Indian Statistical Institute (ISI), Kolkata and ...
Read more: Maha FDA calls for joint efforts with pharma industry to fight against counterfeit drugs

Pharma Reviews: Russian, Indian firms ink deal to produce drugs for HIV

Russian state-run National Immunobiological Company (Nacimbio) on Tuesday announced signing an agreement with Indian pharma firm Mylan ...
Read more: Russian, Indian firms ink deal to produce drugs for HIV

Pharma Reviews: Significant funding opportunities in UK for Indian pharma companies: Geoff Wain

There are significant India-specific funding opportunities in Britain's lifesciences sector, which is already being leveraged by some of the largest Indian ...
Read more: Significant funding opportunities in UK for Indian pharma companies: Geoff Wain

Pharma Reviews: Indian Pharma's sector is losing sheen as prize manufacture

A serious malady afflicts the Indian pharmaceutical sector. Export growth is virtually flat at $16.8 billion and, in fact, has declined a wee bit last fiscal.
Read more: Indian Pharma's sector is losing sheen as prize manufacture

Pharma Reviews: Russian, Indian firms ink deal to produce drugs for HIV

Moscow: Russian state-run National Immunobiological Company (Nacimbio) on Tuesday announced signing an agreement with Indian pharma firm ...
Read more: Russian, Indian firms ink deal to produce drugs for HIV

US FDA News: Urogynecologic Surgical Mesh Implants by Boston Scientific: Notification – Potential for Counterfeit Raw Material

UPDATED 09/19/2017 Updating after extensive review of data and information.
Read more: Urogynecologic Surgical Mesh Implants by Boston Scientific: Notification – Potential for Counterfeit Raw Material

Pharma Reviews: Policy decision in healthcare is hurting industry, investors weary: Preetha Reddy

Mumbai: The National Pharmaceutical Pricing Authority's decision to cut ... “Any policy that impedes innovation will not only make Indian innovators ...
Read more: Policy decision in healthcare is hurting industry, investors weary: Preetha Reddy

Pharma Reviews: PET bottles are safe for pharma packaging : Dr. Rao VSV Vadlamudi

President, Indian Pharmaceutical Association (IPA) and Commonwealth ... and plastic are being majorly used for packaging in the pharma industry.
Read more: PET bottles are safe for pharma packaging : Dr. Rao VSV Vadlamudi

Pharma Reviews: Strong earnings pick-up not likely this fiscal: Nitin Jain, Kotak Mahindra UK

The upside in Indian equities in the rest of the year appears limited as the ... Indian pharma companies have a good balance sheet and they are not ...
Read more: Strong earnings pick-up not likely this fiscal: Nitin Jain, Kotak Mahindra UK

Pharma Reviews: Pharma industry needs to adopt IoT to improve supply chain efficiency: GoComet

Indian pharmaceutical industry, one of the largest exporters of pharmaceuticals in the world, needs to adopt technologies like the Internet of Things ...
Read more: Pharma industry needs to adopt IoT to improve supply chain efficiency: GoComet

Pharma Reviews: Fosun Pharma to acquire 74% stake in Gland Pharma for $1.09 bn

Chinese pharma firm Shanghai Fosun has decided to scale down its ... for manufacturing by Gland Pharma and introducing them to the Indian market.
Read more: Fosun Pharma to acquire 74% stake in Gland Pharma for $1.09 bn

Pharma Reviews: Fosun to buy 74% stake in Gland Pharma

Fosun Shanghai Fosun Pharmaceutical Group Co. Ltd, a unit of China's Fosun Group has agreed to acquire 74 percent of Indian drug company Gland ...
Read more: Fosun to buy 74% stake in Gland Pharma

Pharma Reviews: Shanghai Fosun to buy 74% in Gland Pharma for 7000 cr

Hyderabad: Chinese pharma firm Shanghai Fosun has decided to scale ... and Indian anti-trust filings have been completed,” Fosun Pharma said.
Read more: Shanghai Fosun to buy 74% in Gland Pharma for 7000 cr

Pharma Reviews: Lupin names Jim Loerop as chief corporate development officer

In a statement, the company said that Loerop will lead Lupin's overall ... Several Indian pharma companies are looking at overseas acquisitions to ...
Read more: Lupin names Jim Loerop as chief corporate development officer

Pharma Reviews: Partnerships can buoy healthcare: panellists at VCCircle summit

DG Shah, secretary general of Indian Pharmaceutical Alliance, said the industry has to take care of the weaker segments to be sustainable in the long ...
Read more: Partnerships can buoy healthcare: panellists at VCCircle summit

Pharma Reviews: Fosun Pharma to acquire 74% stake in Gland Pharma for $1.09 bn

Chinese pharma firm Shanghai Fosun has decided to scale down its ... under the relevant Indian foreign investment policies," Fosun Pharma said.
Read more: Fosun Pharma to acquire 74% stake in Gland Pharma for $1.09 bn

Pharma Reviews: China's Fosun Pharma to buy smaller stake in Indian firm Gland Pharma

It said Gland Pharma's founding family wanted to retain a higher stake in the Indian firm because of its good performance. Fosun had previously been ...
Read more: China's Fosun Pharma to buy smaller stake in Indian firm Gland Pharma

Pharma Reviews: JM Financial report on Indian pharma sees focus on emerging markets & volume-driven growth in ...

From R&D initiatives paying off, improved quality compliance, growing attention to emerging markets, Indian pharma industry is moving up the value ...
Read more: JM Financial report on Indian pharma sees focus on emerging markets & volume-driven growth in ...

Pharma Reviews: China's Fosun scales back bid for India's Gland Pharma to $1.1 billion to avoid veto from CCEA

Shanghai Fosun Pharmaceutical Group Co. scaled back its proposed purchase of control in Indian drugmaker Gland Pharma Ltd. to a level that would ...
Read more: China's Fosun scales back bid for India's Gland Pharma to $1.1 billion to avoid veto from CCEA

Pharma Reviews: China's Fosun to buy 74% stake in Gland Pharma for $1.1 bn in revised deal

Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 per cent for $1.1 billion, in a bid to ...
Read more: China's Fosun to buy 74% stake in Gland Pharma for $1.1 bn in revised deal

Pharma Reviews: Bull run resumes; check out these laggards that can give solid returns

Brokerage firm JM Financial in a research report said an assessment of important factors that can deeply influence the Indian pharma industry in the ...
Read more: Bull run resumes; check out these laggards that can give solid returns

Pharma Reviews: China's Fosun Pharma to buy smaller stake in Gland Pharma for $1.1 billion

Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India`s Gland Pharma to 74 percent for $1.1 billion, in a bid to ...
Read more: China's Fosun Pharma to buy smaller stake in Gland Pharma for $1.1 billion

Pharma Reviews: PMO sought report in March: Amid fall in pharmaceutical exports, a commerce dept report 'under ...

The Indian pharmaceutical industry earns around 50 per cent of its revenues from exports. While the Indian pharmaceutical exports rose by ...
Read more: PMO sought report in March: Amid fall in pharmaceutical exports, a commerce dept report 'under ...

Pharma Reviews: Fosun to buy 74% stake in Gland Pharma for $1.1 bn in revised deal

Mumbai: Shanghai Fosun Pharmaceutical Group Co. Ltd, a unit of China's Fosun Group has agreed to acquire 74% of Indian drug company Gland ...
Read more: Fosun to buy 74% stake in Gland Pharma for $1.1 bn in revised deal

Pharma Reviews: China's Fosun Pharma to buy smaller stake in Indian firm for $1.1 billion

BEIJING/MUMBAI (Reuters) - Shanghai Fosun Pharmaceutical Group has agreed to cut the size of the stake it will buy in India's Gland Pharma to 74 ...
Read more: China's Fosun Pharma to buy smaller stake in Indian firm for $1.1 billion

Pharma Reviews: Fosun Group injects new life into Gland Pharma deal

Fosun Pharma said it would spend no more than $25 million for the Indian firm's Enoxaparin prototype sales in the US, when it gets approval there, ...
Read more: Fosun Group injects new life into Gland Pharma deal

Pharma Reviews: China's Fosun Pharma to Buy Smaller Stake in Indian Firm for $1.1Billion

Beijing /Mumbai: Shanghai Fosun Pharmaceutical Group has agreed to cut the size of the stake it will buy in India's Gland Pharma to 74 percent, ...
Read more: China's Fosun Pharma to Buy Smaller Stake in Indian Firm for $1.1Billion

Pharma Reviews: Drug makers dial foreign regulators on quality issues

Indian Pharmaceutical Alliance (IPA), the industry body representing research-based companies, has invited regulators from America, Britain and the ...
Read more: Drug makers dial foreign regulators on quality issues

Pharma Reviews: China's Fosun Pharma to buy smaller stake in Indian pharma firm

A company logo is pictured at the headquarters of Shanghai Fosun Pharma Group in Shanghai, China September 13, 2016. REUTERS/Aly Song/Files.
Read more: China's Fosun Pharma to buy smaller stake in Indian pharma firm

Pharma Reviews: After GST, pharma companies prefer Gujarat over tax havens

After GST, pharma companies prefer Gujarat over tax havens ... Gujarat contributes to around 33 per cent of the national pharmaceutical ... to move up to 40 per cent by 2020, feels the Indian Drug Manufacturers Association (IDMA).
Read more: After GST, pharma companies prefer Gujarat over tax havens

Pharma Reviews: PharmaTechnologyIndex.com MoU with Indo African Chamber to promote business

An MoU was signed between PharmaTechnologyIndex.com Pvt. Ltd., Ahmedabad and Indo African Chamber of Commerce and Industry, Mumbai to ...
Read more: PharmaTechnologyIndex.com MoU with Indo African Chamber to promote business

Pharma Reviews: Equities close flat on weak global cues, profit booking (Roundup)

“Indian shares fell on Friday tracking lower Asian markets, as geo-political ... “Sun Pharmaceutical Industries and Dr. Reddy's Laboratories, which ...
Read more: Equities close flat on weak global cues, profit booking (Roundup)

Pharma Jobs: Research Associate

Company: Precision Staffers
Experience: 1 to 5
location: Bengaluru / Bangalore
Ref: 21251706
Summary: You will be responsible for receiving the samples from customer support, checking for proper labelling, and update them in the lab records.

Read more: Research Associate

Pharma Jobs: Embryologist

Company: Precision Staffers
Experience: 1 to 6
location: Bengaluru / Bangalore
Ref: 21251728
Summary: Field Embryo Biopsy Specialist is required to handle biopsy collection from human embryos of Day 3 and Day 5 stages for our key customers across the country. The position is intended for those looking to work with highly....
Read more: Embryologist

Pharma Reviews: Fate of Centrally-funded projects hangs in balance

The pharma industry here also had lot of hopes that they would get National Institute of Pharma Education and Research (NIPER) to overcome ...
Read more: Fate of Centrally-funded projects hangs in balance

Pharma Reviews: India, Japan need a 'silver bullet' to heal pharma ties

There is a trade deficit of pharmaceutical exports to Japan and less than 2 per cent of the Japanese pharma market comes from India. About 4 per cent ...
Read more: India, Japan need a 'silver bullet' to heal pharma ties

Pharma Reviews: Drug regulators, industry body to conduct workshops on manufacturing norms

Mumbai: At a time when the Indian pharmaceutical sector is drawing flak for non-adherence to quality norms, drug regulators and the industry ...
Read more: Drug regulators, industry body to conduct workshops on manufacturing norms

Pharma Reviews: Pain pills and brand fever: Draft pharma policy comes with few blockbusters

One of the more pleasant ones is the government almost admitting the complicity of Indian pharmaceutical companies in fabricating results of clinical ...
Read more: Pain pills and brand fever: Draft pharma policy comes with few blockbusters

Pharma Reviews: New draft pharma policy will reduce risks like generalisation of mkt: JM Financial

In an interview to CNBC-TV18, Anmol Ganjoo, Director of JM Financial Institutional Securities spoke about his latest report on Indian pharmaceutical ...
Read more: New draft pharma policy will reduce risks like generalisation of mkt: JM Financial

Pharma Reviews: Indian shares fall; North Korea tensions weigh

Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd, which gained in the last three sessions, fell 1.5 percent and 1.1 percent, ...
Read more: Indian shares fall; North Korea tensions weigh

Pharma Reviews: Sensex Edges Higher; Pharma, Banking Shares Lead Gains

Indian shares nudged up on Thursday, as gains in banks and pharma ... Sun Pharmaceutical Industries Ltd climbed more than 2.4 percent, helping the ...
Read more: Sensex Edges Higher; Pharma, Banking Shares Lead Gains

Pharma Reviews: Pharma stocks rise sharply this week on cheap valuations

Shrinking growth in the US, the biggest market for many Indian pharma companies, due to price erosion and regulatory issues, and increasing price ...
Read more: Pharma stocks rise sharply this week on cheap valuations

Pharma Reviews: KPMA wants Kerala govt to frame suitable industrial policies for attracting more entrepreneurs to ...

The volume of medicines that the pharmaceutical industry in Kerala ... companies and the Indian giants are eying Kerala as a profitable market.
Read more: KPMA wants Kerala govt to frame suitable industrial policies for attracting more entrepreneurs to ...

Pharma Reviews: IDMA in assn with NSF Health Sciences, UK to organise Advanced Programme in Pharmaceutical ...

The Indian Drug Manufacturers Association (IDMA) in association with NSF Health Sciences, UK is organising the first ever international education ...
Read more: IDMA in assn with NSF Health Sciences, UK to organise Advanced Programme in Pharmaceutical ...

Pharma Reviews: How to do drugs: The patient in India must be the main beneficiary of a prudent pharma policy

The Indian pharma industry with a FY16 revenue of nearly $35 billion has two major streams of business, international (about $18 billion) and the rest ...
Read more: How to do drugs: The patient in India must be the main beneficiary of a prudent pharma policy

Pharma Reviews: India's pharmaceutical research problem

At 0.83% of gross domestic product, India is among the countries with the lowest ... More regulatory changes are required and Indian pharmaceutical ...
Read more: India's pharmaceutical research problem

Pharma Reviews: Sunrise at sunset point

Indian pharma companies chose pockets in Africa, Asia and the Middle East as natural expansion outposts. They leveraged India's formulation ...
Read more: Sunrise at sunset point

Pharma Reviews: Intas Pharma to bid for $4-bn deals in a month

Intas Pharma to bid for $4-bn deals in a month. Firm beats ... In less than a year, Intas is bidding for three assets worth $4 billion, the biggest bet by Indian pharma overseas. Two of ... And get a daily news letter specific to that industry.
Read more: Intas Pharma to bid for $4-bn deals in a month

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms

Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms

US FDA News: FDA approves new treatment for adults with relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.
Read more: FDA approves new treatment for adults with relapsed follicular lymphoma

US FDA News: FDA approves first biosimilar for the treatment of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.
Read more: FDA approves first biosimilar for the treatment of cancer

US FDA News: FDA permits marketing of mobile medical application for substance use disorder

Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs. The application is not intended to be used to treat opioid dependence.
Read more: FDA permits marketing of mobile medical application for substance use disorder

Pharma Reviews: Nifty up marginally; pharma, banking stocks shine

Sector-wise, pharma gained 2.63 per cent, followed by PSU banks 0.69 per cent, private banks 0.37 per cent, banks 0.32 per cent and auto 0.30 per ...
Read more: Nifty up marginally; pharma, banking stocks shine

Pharma Reviews: CBFC doesn't want Indians to know truth of illegal drug trials: Umeed director

Rajat S Mukherjee adds, "Umeed exposes the dark truth of foreign pharmaceutical companies, who are exploiting the Indian population in the garb of ...
Read more: CBFC doesn't want Indians to know truth of illegal drug trials: Umeed director

Pharma Reviews: Sensex little changed; banks, pharma up

A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, India, February 26, 2016. REUTERS/Shailesh Andrade/ ...
Read more: Sensex little changed; banks, pharma up

Pharma Reviews: Indian shares little changed; banks, pharma up

Sept 14 (Reuters) - Indian shares nudged up on Thursday, as gains in ... Sun Pharmaceutical Industries Ltd climbed more than 2.4 percent, helping ...
Read more: Indian shares little changed; banks, pharma up

Pharma Reviews: Market Now: Sun Pharma, BPCL most active stocks in terms of volume

NEW DELHI: Shares of Sun Pharma (number of shares traded: 0.34 crore), followed by Bharat Petroleum (0.21 crore), REC (0.20 crore) and Indian Oil ...
Read more: Market Now: Sun Pharma, BPCL most active stocks in terms of volume

US FDA News: OriGen VV28F Reinforced Dual Lumen ECMO Catheters: Recall - Potential for Separation of Extension Tube From Hub

Separation could result in required intervention to prevent permanent impairment/damage.
Read more: OriGen VV28F Reinforced Dual Lumen ECMO Catheters: Recall - Potential for Separation of Extension Tube From Hub

Pharma Reviews: Lupin gets USFDA nod to market generic anti-bacterial drug

Lupin is a transnational pharmaceutical company based in Mumbai. It is the 3rd largest Indian pharmaceutical company by revenue. Photo: Mint.
Read more: Lupin gets USFDA nod to market generic anti-bacterial drug

Pharma Reviews: The Indian pharma companies' confidence is now high and it forecasts rapid growth : Yogesh Mudras

The Indian pharma companies' confidence is now high and it forecasts rapid growth : Yogesh In an interview with ETHealthworld, Yogesh Mudras, ...
Read more: The Indian pharma companies' confidence is now high and it forecasts rapid growth : Yogesh Mudras

US FDA News: Diabetes Infusion Sets by Medtronic: Recall - Vent Membrane May be Susceptible to Being Blocked by Fluid

May lead to potential over-delivery of insulin shortly after an infusion set change, which may cause hypoglycemia. Posted 09/12/2017
Read more: Diabetes Infusion Sets by Medtronic: Recall - Vent Membrane May be Susceptible to Being Blocked by Fluid

Pharma Reviews: Patented drug launches help MNCs score over Indian peers

Patented drug launches help MNCs score over Indian peers MUMBAI: At a time when the pharmaceuticals industry is facing the heat with price cuts ...
Read more: Patented drug launches help MNCs score over Indian peers

Pharma Reviews: Bhushan Bazaz bereaved

'Mohan' as he was fondly called by his friends, was the 42nd President of the Indian Pharmaceutical Congress Association (IPCA) for the year 1990; ...
Read more: Bhushan Bazaz bereaved

Pharma Reviews: Pharma stockists see fall in business transactions post-GST: survey

The Indian pharmaceutical market contracted 2.4% on year to Rs9,280 crore in July due to operational issues faced by the industry for GST ...
Read more: Pharma stockists see fall in business transactions post-GST: survey

Pharma Reviews: Uzbek envoy seeks to boost ties with India in aviation, biz

"Arziev announced setting up of a Special Economic Zone in Uzbekistan especially for Indian pharmaceutical companies which are keen to set up ...
Read more: Uzbek envoy seeks to boost ties with India in aviation, biz

Pharma Reviews: Indian pharma market clocks growth of 2.4% in August 2017 to Rs.10317 crore

Indian Pharmaceutical Market (IPM) registered a growth of 2.4 per cent with sales of Rs.10,317 crore during August 2017. According to AIOCD ...
Read more: Indian pharma market clocks growth of 2.4% in August 2017 to Rs.10317 crore

Pharma Reviews: Patented drug launches help MNCs score over Indian peers

While Indian companies still control almost 80% of the Rs 1 lakh crore pharma market in the country, the strategy of launching specialised patented ...
Read more: Patented drug launches help MNCs score over Indian peers

Pharma Reviews: India's limited entrepreneurship

If the call for globalisation and free international market access is vital for ... Unfortunately, India is lagging far behind in manufacturing — basic or ... Coal India, Sun Pharmaceutical Industries, Infosys, State Bank of India (SBI) and ...
Read more: India's limited entrepreneurship

Pharma Reviews: After GST jitters, pharma market back on growth track in August

After GST jitters, pharma market back on growth track in August ... Tax (GST), the Indian pharmaceutical market (IPM) was back on track in August, ...
Read more: After GST jitters, pharma market back on growth track in August

Pharma Reviews: Made in India – The Syringe & Futuristic Safe Injection System-2020

The disposable drug cartridge, thus, provides a smart packaging technology .... The Indian Pharmaceuticals Industry (IPI) earns around 70 per cent of ...
Read more: Made in India – The Syringe & Futuristic Safe Injection System-2020

Pharma Reviews: We are investing 100 mn pounds in a manufacturing facility in Bangalore: Annaswamy Vaidheesh ...

The Pharmaceuticals sector, already being India's one of the fastest growing industries, is projected to grown at a stable and fast pace irrespective of ...
Read more: We are investing 100 mn pounds in a manufacturing facility in Bangalore: Annaswamy Vaidheesh ...

Pharma Reviews: An Agenda For The Next 30 Years

Today, India is called as the 'pharmacy of the world', which has been the result of a long and arduous journey. In 1947, India's pharmaceutical market ...
Read more: An Agenda For The Next 30 Years

Pharma Reviews: Lupin plans to bring new class of diabetes drug to India

Mumbai: Lupin Ltd, India's second largest pharmaceutical company, is looking to enhance its diabetes drugs offering in the domestic market by ...
Read more: Lupin plans to bring new class of diabetes drug to India

Pharma Reviews: Govt proposal to scrap loan licensing in draft pharma policy note faces flak

In a representation made to the government last week, Deepnath Roy Chowdhury, national president of industry body Indian Drug Manufacturers ...
Read more: Govt proposal to scrap loan licensing in draft pharma policy note faces flak

Pharma Reviews: Multinational firms dominate vitamins market in India

India's share in the global nutraceuticals market is set to rise, but the ... D G Shah, secretary general of the Indian Pharmaceutical Alliance, said that ...
Read more: Multinational firms dominate vitamins market in India

Pharma Reviews: CCI To Study Pricing, Business Practices In Healthcare Sector

Fair trade regulator Competition Commission of India (CCI) plans to carry out a detailed study on pharmaceutical and healthcare segments, including ...
Read more: CCI To Study Pricing, Business Practices In Healthcare Sector

Pharma Reviews: CCI to study pricing, biz practices in healthcare sector

Competition Commission of India (CCI) is planning to carry out a detailed study on pharmaceutical and healthcare segments, including differential ...
Read more: CCI to study pricing, biz practices in healthcare sector

Pharma Reviews: Pharma department moves to wrestle NPPA's special powers to cap drug prices

The decision was criticised by Indian and multinational industry groups as “discretionary” and challenged separately in courts. The Bombay High ...
Read more: Pharma department moves to wrestle NPPA's special powers to cap drug prices

Pharma Reviews: Gujarat govt fasttracks process: New pharma licence now in 60 days only

Rupani added, “Similarly, we have also reduced the time taken for renewal of licence for drug manufacturers to 60 days from 180 days.
Read more: Gujarat govt fasttracks process: New pharma licence now in 60 days only

Pharma Reviews: India becoming next global leader in diagnostic solutions

India's competitive advantage also lies in the increased success rate of Indian companies in getting Abbreviated New Drug Application (ANDA) ...
Read more: India becoming next global leader in diagnostic solutions

Pharma Reviews: Gujarat govt fast-tracks licences issuance & renewals for pharma industry

"I have announced today that the licences needed for new drug manufacturers has been reduced to 60 days from the earlier 120 days or four days.
Read more: Gujarat govt fast-tracks licences issuance & renewals for pharma industry

Pharma Reviews: The 'Pure Veg' Prescription

The notice has caused panic in the Indian pharmaceutical industry because if implemented, it will raise the cost of production and increase the price of ...
Read more: The 'Pure Veg' Prescription

Pharma Reviews: Indian retail sector projected to touch $700 bn by 2020, states report

Indian retail sector projected to touch $700 bn by 2020, states report ... Sanjeev Navangul, managing director, Janssen India, pharmaceutical division, ...
Read more: Indian retail sector projected to touch $700 bn by 2020, states report

Pharma Reviews: CCI to study unfair practices in Indian pharma, healthcare

“In the enforcement experience of the Commission, several anti-competitive practices in the Indian pharmaceutical and healthcare sector have come ...
Read more: CCI to study unfair practices in Indian pharma, healthcare

US FDA News: Baby Organic Liquid Formula by Garden of Life: Recall - Directions For Use May Be Misinterpreted

If not administered precisely following the labeled instructions, the product may present difficulties in swallowing and potentially pose a choking hazard due to the thickness of the liquid.
Read more: Baby Organic Liquid Formula by Garden of Life: Recall - Directions For Use May Be Misinterpreted

Pharma Reviews: Indian biotech leaders visit Birmingham for life science facilities briefing

Birmingham, Sept 8 (IBNS): A delegation of Indian biotech company leaders ... hub for biotechnology and has a world-class pharmaceutical industry.
Read more: Indian biotech leaders visit Birmingham for life science facilities briefing

Pharma Reviews: 'Pharma will get boost from GST'

... industry in the state will get a major boost, according to the estimates of the Indian Drug Manufacturers Association (IDMA) - Gujarat State Board.
Read more: 'Pharma will get boost from GST'

Product Recall Alerts: MHRA issues drug alert after drugs mislabelled

... Healthcare products Regulatory Agency (MHRA) has issued a drug alert for a ... so the affected batches are not being recalled by the manufacturer.
Read more: MHRA issues drug alert after drugs mislabelled

Pharma Reviews: Market Live: Sensex, Nifty trade higher, pharma, realty stocks drop

However, analysts cautioned Indian markets were unlikely to gain much, with ... Cadila Healthcare Ltd 2.5%, Sun Pharmaceuticals Industries Ltd 2.2%, ...
Read more: Market Live: Sensex, Nifty trade higher, pharma, realty stocks drop

Pharma Reviews: IDMA appeals to govt not to discontinue loan licensing and P2P for survival of pharma SMEs

The Indian Drug Manufacturers' Association (IDMA) has urged the government not to discontinue loan licensing and P2P for the survival and ...
Read more: IDMA appeals to govt not to discontinue loan licensing and P2P for survival of pharma SMEs

Pharma Reviews: Indian pharma needs to adopt unique labelling options to detect & stall fake drug sale: Dr. Piyush ...

Indian pharma industry needs to adopt unique labelling options to detect and stall fake drug sale, said Dr Piyush Gupta, Associate Director, GNH India.
Read more: Indian pharma needs to adopt unique labelling options to detect & stall fake drug sale: Dr. Piyush ...

Pharma Reviews: Drug regulators gets trained on regulatory aspects of data integrity, impurity profiling

The industry has strong capabilities in product development. Also, Indian pharmaceutical companies have the largest share of DMFs and ANDAs ...
Read more: Drug regulators gets trained on regulatory aspects of data integrity, impurity profiling

Pharma Reviews: 'Pharma will get boost from GST'

Ahmedabad: With the implementation of goods and services tax (GST), the pharmaceuticals manufacturing industry in the state will get a major boost, ...
Read more: 'Pharma will get boost from GST'

Pharma Reviews: Reduce supply of codeine-based cough syrups: Narcotics Control Bureau tells DCGI

In a setback for pharmaceutical companies, the Narcotics Control Bureau (NCB) has asked the Drug Controller General of India (DCGI) to ...
Read more: Reduce supply of codeine-based cough syrups: Narcotics Control Bureau tells DCGI

Pharma Reviews: Ahmedabad to host 8th edition of Pharmac India

The expo to be held between November 7-9 in Ahmedabad, will chart a new path for the pharma industry at a time when three dedicated clusters for ...
Read more: Ahmedabad to host 8th edition of Pharmac India

Pharma Reviews: Indiabulls Group plans foray into pharma business

Industry sources told CNBC-TV18 that Indiabulls has lined up about 300 generic products that they are marketing in the Indian pharma market to ...
Read more: Indiabulls Group plans foray into pharma business

Pharma Reviews: Tao Guang Yang Hui And Doklam

The Indian pharmaceutical industry imports 60 per cent of its raw material from China. With its sheer dominance over world trade and massive forex ...
Read more: Tao Guang Yang Hui And Doklam

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy

Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy

US FDA News: Activase (alteplase) 100mg by Genentech: Recall - Lack of Sterility Assurance

The use of impacted Sterile Water for Injection could result in adverse events such as fever, chills, phlebitis, and granuloma or more severe adverse events such as sepsis or invasive systemic infections.
Read more: Activase (alteplase) 100mg by Genentech: Recall - Lack of Sterility Assurance

Pharma Reviews: DoP to introduce UCPMP under Essential Commodities Act to ensure 100% compliance by ...

Expressing concern over DoP decision to bring UCPMP under EC Act, DG Shah, Secretary General, Indian Pharmaceutical Alliance said “The ...
Read more: DoP to introduce UCPMP under Essential Commodities Act to ensure 100% compliance by ...

Pharma Reviews: Law to check unethical marketing practices in pharma faces delay due to legal tangle

DG Shah, Secretary General of Indian Pharmaceutical Alliance (IPA) that represent large drug makers is of the view that the UCPMP under the current ...
Read more: Law to check unethical marketing practices in pharma faces delay due to legal tangle

Pharma Reviews: Mylan looks to sell off Vizag formulations unit it acquired in 2012

A senior management executive of a Hyderabad-based pharmaceutical ... While Mylan has done a series of acquisitions in India during the past ten ...
Read more: Mylan looks to sell off Vizag formulations unit it acquired in 2012

US FDA News: Intra-Aortic Balloon Pumps by Datascope/MAQUET: Class I Recall - False Blood Detection Alarm, Ingress of Fluid Into Pump

If therapy is stopped during use without a replacement IABP available, device failure may result in immediate and serious adverse health consequences, including death.
Read more: Intra-Aortic Balloon Pumps by Datascope/MAQUET: Class I Recall - False Blood Detection Alarm, Ingress of Fluid Into Pump

US FDA News: Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing

Too much potassium in the blood can cause problems with heart rhythm, which in rare cases can be fatal.
Read more: Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing

Pharma Reviews: Sensex Slumps 160 Points to 31649, Nifty at 9911 on North Korea Jitters

Sun Pharmaceuticals Industries Ltd fell 3.2%, Divi's Laboratories Ltd 3.2% ... The Indian rupee slipped in the early trade on Wednesday by opening ...
Read more: Sensex Slumps 160 Points to 31649, Nifty at 9911 on North Korea Jitters

Pharma Reviews: India cannot be ignored for global clinical trials; new regulations restore clarity & confidence: Tim ...

We are keen to support Indian pharma / life sciences companies and those across Asia. Also Australian companies are looking to connect with India ...
Read more: India cannot be ignored for global clinical trials; new regulations restore clarity & confidence: Tim ...

Pharma Reviews: A disruptive 'Patanjali' moment awaits Indian pharma

There is a Patanjali moment underway in the Indian pharmaceutical industry that is likely hurting pharmaceutical companies and everyone linked to it.
Read more: A disruptive 'Patanjali' moment awaits Indian pharma

Pharma Reviews: Chemical, fertiliser, pharma turnover at ₹ 13.5 lakh crore

Fertiliser, pharmaceutical and chemical—petrochemical sectors have become a growth engine of Indian economy, clocking a combined turnover of ...
Read more: Chemical, fertiliser, pharma turnover at ₹ 13.5 lakh crore

Pharma Reviews: Pharma major Mylan puts Andhra Pradesh plant on sale

The US-headquartered company has made its presence felt in the Indian pharmaceutical market through several acquisitions. Since 2007, the ...
Read more: Pharma major Mylan puts Andhra Pradesh plant on sale

US FDA News: Hydromorphone HCl Injection, USP 2 mg/mL, and Levophed (Norepinephrine Bitartrate Injection, USP) 4 mg/4 mL (1 mg/mL) Vial by Hospira: Recall - Lack of Sterility Assurance

If impacted product is administered to a patient, adverse events ranging from fever, chills, and malaise, to severe adverse events such as septicemia, bacterial meningitides and wound infection could occur.
Read more: Hydromorphone HCl Injection, USP 2 mg/mL, and Levophed (Norepinephrine Bitartrate Injection, USP) 4 mg/4 mL (1 mg/mL) Vial by Hospira: Recall - Lack of Sterility Assurance

Pharma Reviews: Stocks that have fallen out of favour and why

Mumbai: While Indian markets have enjoyed a good run this year, here is a quick ... For most leading Indian pharmaceutical companies, the US market ...
Read more: Stocks that have fallen out of favour and why

Pharma Reviews: Pharma giant Novartis names Indian-origin Vas Narasimhan as CEO

Narasimhan, a Harvard-trained medical doctor, is currently global head of Drug Development and chief medical officer of the company.
Read more: Pharma giant Novartis names Indian-origin Vas Narasimhan as CEO

Pharma Reviews: Over 200 BSE-500 stocks under-perform since August

... class action lawsuits filed against Indian pharmaceutical companies increased in the recent times. Natco Pharma, Ajanta Pharma, Ipca Laboratories, ...
Read more: Over 200 BSE-500 stocks under-perform since August

Pharma Reviews: Swiss pharma giant Novartis appoints Indian-origin Vasant Narasimhan as CEO

Swiss pharmaceutical giant Novartis appoints Indian origin Harvard doctor Vasant Narasimhan as the chief executive officer (CEO), reports Bloomberg ...
Read more: Swiss pharma giant Novartis appoints Indian-origin Vasant Narasimhan as CEO

Pharma Reviews: If market stays here or even corrects 5-7%, it will be healthy: Raamdeo Agrawal

If market stays here or even corrects 5-7%, it will be healthy: Raamdeo .... Indian pharma has its own unique position in the international space.
Read more: If market stays here or even corrects 5-7%, it will be healthy: Raamdeo Agrawal

Pharma Reviews: Pharma firm, bank officials face charges of cheating SBI of Rs 157 crore

Pharma firm, bank officials face charges of cheating SBI of Rs 157 crore ... bank officials for cheating the State Bank of India (SBI) of Rs 157.96 crore.
Read more: Pharma firm, bank officials face charges of cheating SBI of Rs 157 crore

Pharma Reviews: Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis

Indians have made it to leadership roles in other big pharma companies too at the global level. Udit Batra serves on the executive board of German ...
Read more: Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis

Pharma Reviews: Novartis puts Indian doctor from Harvard in charge as CEO Jiminez leaves

The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel, Switzerland. REUTERS/Arnd Wiegmann/File Photo.
Read more: Novartis puts Indian doctor from Harvard in charge as CEO Jiminez leaves

Pharma Reviews: Sun Pharma sees decline in revenues for FY18

Pharma major Sun Pharmaceutical Industries said its short-term outlook ... "In the Indian market, there is uncertainty amongst the trade channels due ...
Read more: Sun Pharma sees decline in revenues for FY18

Pharma Reviews: Indian drug makers need to raise quality bar as US strengthens audits

India has the highest number of US FDA-approved plants outside the US, ... Indian pharmaceutical companies must take a holistic approach to raise ...
Read more: Indian drug makers need to raise quality bar as US strengthens audits

Pharma Reviews: Pharma strategy: GlaxoSmithKline sets up first team for acquisitions in 93 years

A British Airways airplane flies past a signage of pharmaceutical giant ... USFDA alerts on Indian pharma companies have increased over the past few ...
Read more: Pharma strategy: GlaxoSmithKline sets up first team for acquisitions in 93 years

Pharma Reviews: Credit Suisse Sees Tough Times Ahead For Sun Pharma

Earlier, Sun Pharma had declared in its annual report that the company ... Ranbaxy's growth in India, although, is only a mid-single digit figure, said ...
Read more: Credit Suisse Sees Tough Times Ahead For Sun Pharma

Pharma Reviews: Ajanta Pharma gets USFDA nod for Parkinson's disease tablet

In a BSE filing, Ajanta Pharma said it has recieved "final approval for ... of products that the company has developed for the US market, it added.
Read more: Ajanta Pharma gets USFDA nod for Parkinson's disease tablet

Pharma Reviews: The long-term story of India's pharma sector is intact: Sandeep Nayak, Centrum Broking Ltd

Investing in equities requires one to keep an eye on the company and review the investment rational on a regular basis, Sandeep Nayak tells ET ...
Read more: The long-term story of India's pharma sector is intact: Sandeep Nayak, Centrum Broking Ltd

Pharma Reviews: DCGI plans surprise tests in labs to check drug quality

There are about 150-200 such drug testing laboratories in India that test drugs, cosmetics and other pharmaceutical ingredients manufactured.
Read more: DCGI plans surprise tests in labs to check drug quality

Pharma Reviews: Sun Pharma sees single-digit decline in revenue for 2017-18

Dilip Shanghvi said in Sun Pharmaceutical Industries's annual report that ... as the US generics industry is facing rapidly changing market dynamics. ... “In the Indian market, there is uncertainty amongst the trade channels due to the ...
Read more: Sun Pharma sees single-digit decline in revenue for 2017-18

Pharma Reviews: Sun Pharma sees single-digit decline in revenues for FY18

Mumbai, Sep 3 () Pharma major Sun Pharmaceutical Industries said its ... "In the Indian market, there is uncertainty amongst the trade channels due to ...
Read more: Sun Pharma sees single-digit decline in revenues for FY18

Pharma Reviews: Undergo training in drug quality control, pharmacy students told

Meeting of minds: NIB Director Surinder Singh inaugurating the ninth Indian Pharmaceutical Association Students Forum Congress in ...
Read more: Undergo training in drug quality control, pharmacy students told

Pharma Reviews: 'Never settle for mediocrity; it is worse than failure'

Being in the software industry, this looked to me as the equivalent of getting the source ... No pharma company in India is our customer even today.
Read more: 'Never settle for mediocrity; it is worse than failure'

Pharma Reviews: IT may offer some tactical trading opportunities, stay away from pharma: BNP Paribas

"So, in a nutshell we do have some small presence of Indian IT in our model portfolio. However we do not have any of the Indian pharmaceutical ...
Read more: IT may offer some tactical trading opportunities, stay away from pharma: BNP Paribas

Pharma Reviews: Australia gears up to chip in its expertise in digital health & lifesciences for India

With the Union government focus on Digital India, the Australian ... While Indian healthcare sector is aggressively pursuing the digital path, our ... Indian pharma and biotech enterprises can collaborate for research and manufacture.
Read more: Australia gears up to chip in its expertise in digital health & lifesciences for India

Pharma Reviews: Consolidation of pharma distributors in US and mergers put pressure on profit margins of Indian ...

The profitability of Indian pharmaceuticals companies has remained under pressure due to consolidation of pharmaceutical distributors in the USA, ...
Read more: Consolidation of pharma distributors in US and mergers put pressure on profit margins of Indian ...

US FDA News: Unexpired Lots of Oxytocin Compounded with Either Lactated Ringers or Lactated Ringers and Dextrose by PharMEDium - Recall - Sub-Potency

An extreme and unexpected reduction in dose than expected could lead to a delay in treatment, disruption of clinical care of the patient, and worsening of patient's conditions.
Read more: Unexpired Lots of Oxytocin Compounded with Either Lactated Ringers or Lactated Ringers and Dextrose by PharMEDium - Recall - Sub-Potency

US FDA News: Alcohol Pads or Benzalkonium Chloride Antiseptic Towelettes by Foshan Flying Medical Products: FDA Alert - Lack of Sterility Assurance and Other Quality Issues

The use of these alcohol pads and antiseptic towelettes could cause infections.
Read more: Alcohol Pads or Benzalkonium Chloride Antiseptic Towelettes by Foshan Flying Medical Products: FDA Alert - Lack of Sterility Assurance and Other Quality Issues

Pharma Reviews: Class-action lawsuits against Indian pharma companies on the rise

The number of class action lawsuits filed against Indian pharmaceutical companies has gone up in recent times. With the US law firms alleging ...
Read more: Class-action lawsuits against Indian pharma companies on the rise

US FDA News: FDA clears mammography device with option for patient-assisted compression

Today, the U.S. Food and Drug Administration cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram x-ray is taken.
Read more: FDA clears mammography device with option for patient-assisted compression

Pharma Reviews: Private sector Indian lenders a good bet: Manishi Raychaudhuri

So, in a nutshell we do have some small presence of Indian IT in our model portfolio. However we do not have any of the Indian pharmaceutical stocks ...
Read more: Private sector Indian lenders a good bet: Manishi Raychaudhuri

Pharma Reviews: Drug Controller for a single window system of governance

He says it could go a long way for the sector as the "Indian pharma industry has the potential to be a growth engine for the Indian economy since India ...
Read more: Drug Controller for a single window system of governance

US FDA News: FDA approves Mylotarg for treatment of acute myeloid leukemia

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who have not responded to initial treatment (refractory).
Read more: FDA approves Mylotarg for treatment of acute myeloid leukemia

Pharma Reviews: Indian Medical Devices Industry The Next Big Thing

India is a rapidly growing healthcare market. While pharma sector dominates the overall healthcare market in India, the medical electronics devices ...
Read more: Indian Medical Devices Industry The Next Big Thing

Pharma Reviews: Explained: What Technology has in Store for Healthcare Industry

Experts predict that the Indian pharmaceutical market has the potential to double over the next four years and triple over the next decade, but it is ...
Read more: Explained: What Technology has in Store for Healthcare Industry

Pharma Reviews: Draft pharma policy: NPPA raises concerns over plan to dilute its powers

New Delhi: India's drug pricing regulator has raised concerns over the draft pharmaceutical policy that proposes to dilute and crimp its powers by ...
Read more: Draft pharma policy: NPPA raises concerns over plan to dilute its powers

Pharma Reviews: With US generic drug market in chaos, Indian upstarts rise

The most recent earnings reports across the generic drug industry read like dispatches from the front lines of a price war, with their U.S. businesses ...
Read more: With US generic drug market in chaos, Indian upstarts rise